Association between use of a scalp cooling device and alopecia after chemotherapy for breast cancer

JAMA - Journal of the American Medical Association

Volumn 317, Issue 6, 2017, Pages 606-614

  Rugo, Hope S ^a   Klein, Paula ^b   Melin, Susan Anitra ^c   Hurvitz, Sara A ^d   Melisko, Michelle E ^a   Moore, Anne ^e   Park, Glen ^f   Mitchel, Jules ^f   Bågeman, Erika ^g   D'Agostino, Ralph B ^h   Ver Hoeve, Elizabeth S ^i,j   Esserman, Laura ^a   Cigler, Tessa ^e  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^c WAKE FOREST BAPTIST HEALTH   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e WEILL CORNELL MEDICAL COLLEGE   (United States)

^f Target Health Inc   (United States)

^g Dignitana AB   (Sweden)

^h WAKE FOREST SCHOOL OF MEDICINE   (United States)

ⁱ Och Spine at New York Presbyterian Hospitals   (United States)

^j CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CARBOPLATIN; CYCLOPHOSPHAMIDE; DOCETAXEL; DOXORUBICIN; PACLITAXEL; PERTUZUMAB; TRASTUZUMAB; ANTHRACYCLINE; BRIDGED COMPOUND; TAXANE; TAXOID;

ADJUVANT THERAPY; ADULT; AGE; AGED; ALOPECIA; ARTICLE; ASIAN; BLACK PERSON; BREAST CANCER; CANCER ADJUVANT THERAPY; CANCER STAGING; CAUCASIAN; COHORT ANALYSIS; COOLING; DEAN SCALE; DERMATOLOGICAL EQUIPMENT; DISEASE SEVERITY; EARLY CANCER; FEMALE; FOLLOW UP; HEAD DISCOMFORT; HEADACHE; HUMAN; LOW TEMPERATURE; MAJOR CLINICAL STUDY; MEDICAL DEVICE COMPLICATION; MULTICENTER STUDY; MULTIPLE CYCLE TREATMENT; NEOADJUVANT THERAPY; PHYSICAL ATTRACTIVENESS; PROSPECTIVE STUDY; PRURITUS; QUALITY OF LIFE; RATING SCALE; SCALP COOLING; SCALP COOLING DEVICE; SKIN PAIN; TREATMENT DURATION; UNITED STATES; ADJUVANT CHEMOTHERAPY; ADVERSE EFFECTS; BREAST NEOPLASMS; CHEMICALLY INDUCED; CLINICAL TRIAL; EVALUATION STUDY; INDUCED HYPOTHERMIA; MEDICAL ILLUSTRATION; MIDDLE AGED; PATHOLOGY; PHOTOGRAPHY; PROCEDURES; PSYCHOLOGY; SCALP;

ADULT; AGED; ALOPECIA; ANTHRACYCLINES; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BREAST NEOPLASMS; BRIDGED-RING COMPOUNDS; CHEMOTHERAPY, ADJUVANT; FEMALE; HEADACHE; HUMANS; HYPOTHERMIA, INDUCED; MEDICAL ILLUSTRATION; MIDDLE AGED; NEOADJUVANT THERAPY; PHOTOGRAPHY; PROSPECTIVE STUDIES; QUALITY OF LIFE; SCALP; TAXOIDS;

EID: 85014650556     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.2016.21038     Document Type: Article

References (34)

1. Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J, Jemal A. Global cancer statistics, 2012. CA Cancer J Clin. 2015;65(2):87-108.
2. Hesketh PJ, Batchelor D, Golant M, Lyman GH, Rhodes N, Yardley D. Chemotherapy-induced alopecia: psychosocial impact and therapeutic approaches. Support Care Cancer. 2004;12(8): 543-549.
3. van den Hurk CJ, Mols F, Vingerhoets AJ, Breed WP. Impact of alopecia and scalp cooling on the well-being of breast cancer patients. Psychooncology. 2010;19(7):701-709.
4. Shin H, Jo SJ, Kim DH, Kwon O, Myung SK. Efficacy of interventions for prevention of chemotherapy-induced alopecia: a systematic review and meta-analysis. Int J Cancer. 2015;136(5): E442-E454.
5. BreedW, van den Hurk C, Peerbooms M. Presentation, impact and prevention of chemotherapy-induced hair loss: scalp cooling potentials and limitations. Expert Rev Dermatol. 2011;6:109-125.
6. Bow J, Friberg L, Gaardsting O, Hansen M. Frontal subcutaneous blood flow, and epi- and subcutaneous temperatures during scalp cooling in normal man. Scand J Clin Lab Invest. 1985;45(6): 505-508.
7. Janssen FP, Rajan V, SteenbergenW, van Leeuwen GM, van Steenhoven AA. The relationship between local scalp skin temperature and cutaneous perfusion during scalp cooling. Physiol Meas. 2007;28(8):829-839.
8. Dean JC, Salmon SE, Griffith KS. Prevention of doxorubicin-induced hair loss with scalp hypothermia. N Engl J Med. 1979;301(26):1427-1429.
9. Ridderheim M, Bjurberg M, Gustavsson A. Scalp hypothermia to prevent chemotherapy-induced alopecia is effective and safe: a pilot study of a new digitized scalp-cooling system used in 74 patients. Support Care Cancer. 2003;11(6):371-377.
10. van den Hurk CJ, van de Poll-Franse LV, Breed WP, Coebergh JW, Nortier JW. Scalp cooling to prevent alopecia after chemotherapy can be considered safe in patients with breast cancer. Breast. 2013;22(5):1001-1004.
11. Lemieux J, Amireault C, Provencher L, Maunsell E. Incidence of scalp metastases in breast cancer: a retrospective cohort study in women who were offered scalp cooling. Breast Cancer Res Treat. 2009;118(3):547-552.
12. Rugo H, Melin A. Expert statement on scalp cooling with adjuvant/neoadjuvant chemotherapy for breast cancer and the risk of scalp metastases. Presented at: St Gallen 13th International Breast Cancer Conference; March 13-16, 2013; St Gallen, Switzerland.
13. Lemieux J, Provencher L, Perron L, et al. No effect of scalp cooling on survival among women with breast cancer. Breast Cancer Res Treat. 2015;149(1):263-268.
14. McAndrews PJ. Degree of hair loss. http://www.americanhairloss.org/women-hair-loss/degree-of-hair-loss.asp. Accessed January 2, 2016.
15. Trüeb RM. Chemotherapy-induced alopecia. Semin Cutan Med Surg. 2009;28(1):11-14.
16. Ekwall EM, Nygren LM, Gustafsson AO, Sorbe BG. Determination of the most effective cooling temperature for the prevention of chemotherapy-induced alopecia. Mol Clin Oncol. 2013;1(6):1065-1071.
17. Aaronson NK, Ahmedzai S, Bergman B, et al. The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst. 1993;85(5):365-376.
18. Komen MM, Smorenburg CH, van den Hurk CJ, Nortier JW. Factors influencing the effectiveness of scalp cooling in the prevention of chemotherapy-induced alopecia. Oncologist. 2013; 18(7):885-891.
19. Grevelman EG, Breed WP. Prevention of chemotherapy-induced hair loss by scalp cooling. Ann Oncol. 2005;16(3):352-358.
20. van den Hurk CJ, Breed WP, Nortier JW. Short post-infusion scalp cooling time in the prevention of docetaxel-induced alopecia. Support Care Cancer. 2012;20(12):3255-3260.
21. Giordano SH, Lin YL, Kuo YF, Hortobagyi GN, Goodwin JS. Decline in the use of anthracyclines for breast cancer. J Clin Oncol. 2012;30(18):2232-2239.
22. Cigler T, Isseroff D, Fiederlein B, et al. Efficacy of scalp cooling in preventing chemotherapyinduced alopecia in breast cancer patients receiving adjuvant docetaxel and cyclophosphamide chemotherapy. Clin Breast Cancer. 2015;15(5): 332-334.
23. Friedrichs K, Carstensen MH. Successful reduction of alopecia induced by anthracycline and taxane containing adjuvant chemotherapy in breast cancer-clinical evaluation of sensor-controlled scalp cooling. Springerplus. 2014;3:500.
24. van den Hurk CJ, van den Akker-van Marle ME, Breed WP, van de Poll-Franse LV, Nortier JW, Coebergh JW. Impact of scalp cooling on chemotherapy-induced alopecia, wig use and hair growth of patients with cancer. Eur J Oncol Nurs. 2013;17(5):536-540.
25. Kargar M, Sarvestani RS, Khojasteh HN, Heidari MT. Efficacy of penguin cap as scalp cooling system for prevention of alopecia in patients undergoing chemotherapy. J Adv Nurs. 2011;67(11): 2473-2477.
26. Protièr e C, Evans K, Camerlo J, et al. Efficacy and tolerance of a scalp-cooling system for prevention of hair loss and the experience of breast cancer patients treated by adjuvant chemotherapy. Support Care Cancer. 2002;10(7):529-537.
27. Betticher DC, Delmore G, Breitenstein U, et al. Efficacy and tolerability of two scalp cooling systems for the prevention of alopecia associated with docetaxel treatment. Support Care Cancer. 2013;21(9):2565-2573.
28. van den Hurk CJ, Peerbooms M, van de Poll-Franse LV, Nortier JW, Coebergh JW, Breed WP. Scalp cooling for hair preservation and associated characteristics in 1411 chemotherapy patients-results of the Dutch Scalp Cooling Registry. Acta Oncol. 2012;51(4):497-504.
29. Roe H. Chemotherapy-induced alopecia: advice and support for hair loss. Br J Nurs. 2011;20(10):S4-S11.
30. Batchelor D. Hair and cancer chemotherapy: consequences and nursing care-a literature study. Eur J Cancer Care (Engl). 2001;10(3):147-163.
31. Lemieux J, Maunsell E, Provencher L. Chemotherapy-induced alopecia and effects on quality of life among women with breast cancer: a literature review. Psychooncology. 2008;17(4): 317-328.
32. van den Hurk CJ, Winstanley J, Young A, Boyle F. Measurement of chemotherapy-induced alopecia-time to change. Support Care Cancer. 2015;23(5):1197-1199.
33. Nangia J, Wang T, Osborne C, et al. Effect of a scalp cooling device on alopecia in women undergoing chemotherapy for breast cancer: the SCALP randomized clinical trial. JAMA. doi: 10.1001/jama.2016.20939
34. Rugo HS, Serrurier KM, Melisko A, et al. Use of the DigniCap™ system to prevent hair loss in women receiving chemotherapy (CTX) for stage I breast cancer (BC). Cancer Res. 2012;72(24 suppl):A2.